Cargando…
An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is app...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866782/ https://www.ncbi.nlm.nih.gov/pubmed/16451613 http://dx.doi.org/10.1186/1471-2156-6-S1-S152 |
_version_ | 1782133326980579328 |
---|---|
author | Suarez, Brian K Taylor, Chelsea Bertelsen, Sarah Bierut, Laura J Dunn, Gerald Jin, Carol H Kauwe, John SK Paterson, Andrew D Hinrichs, Anthony L |
author_facet | Suarez, Brian K Taylor, Chelsea Bertelsen, Sarah Bierut, Laura J Dunn, Gerald Jin, Carol H Kauwe, John SK Paterson, Andrew D Hinrichs, Anthony L |
author_sort | Suarez, Brian K |
collection | PubMed |
description | The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is approximately 8.6 times greater than for the Illumina platform, when both platforms make a genotypic call, the agreement is an impressive 99.85%. To determine if disputed genotypes can be resolved without sequencing, we studied recombination in the region of the discrepancy for the most discrepant SNP rs958883 (typed by Illumina) and tsc02060848 (typed by Affymetrix). We find that the number of inferred recombinants is substantially higher for the Affymetrix genotypes compared to the Illumina genotypes. We illustrate this with pedigree 10043, in which 3 of 7 versus 0 of 7 offspring must be double recombinants using the genotypes from the Affymetrix and the Illumina platforms, respectively. Of the 36 SNPs with one or more discrepancies, we identified a subset that appears to cluster in families. Some of this clustering may be due to the presence of a second segregating SNP that obliterates a XbaI site (the restriction enzyme used in the Affymetrix platform), resulting in a fragment too long (>1,000 bp) to be amplified. |
format | Text |
id | pubmed-1866782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18667822007-05-11 An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms Suarez, Brian K Taylor, Chelsea Bertelsen, Sarah Bierut, Laura J Dunn, Gerald Jin, Carol H Kauwe, John SK Paterson, Andrew D Hinrichs, Anthony L BMC Genet Proceedings The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is approximately 8.6 times greater than for the Illumina platform, when both platforms make a genotypic call, the agreement is an impressive 99.85%. To determine if disputed genotypes can be resolved without sequencing, we studied recombination in the region of the discrepancy for the most discrepant SNP rs958883 (typed by Illumina) and tsc02060848 (typed by Affymetrix). We find that the number of inferred recombinants is substantially higher for the Affymetrix genotypes compared to the Illumina genotypes. We illustrate this with pedigree 10043, in which 3 of 7 versus 0 of 7 offspring must be double recombinants using the genotypes from the Affymetrix and the Illumina platforms, respectively. Of the 36 SNPs with one or more discrepancies, we identified a subset that appears to cluster in families. Some of this clustering may be due to the presence of a second segregating SNP that obliterates a XbaI site (the restriction enzyme used in the Affymetrix platform), resulting in a fragment too long (>1,000 bp) to be amplified. BioMed Central 2005-12-30 /pmc/articles/PMC1866782/ /pubmed/16451613 http://dx.doi.org/10.1186/1471-2156-6-S1-S152 Text en Copyright © 2005 Suarez et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Proceedings Suarez, Brian K Taylor, Chelsea Bertelsen, Sarah Bierut, Laura J Dunn, Gerald Jin, Carol H Kauwe, John SK Paterson, Andrew D Hinrichs, Anthony L An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title | An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title_full | An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title_fullStr | An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title_full_unstemmed | An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title_short | An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
title_sort | analysis of identical single-nucleotide polymorphisms genotyped by two different platforms |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866782/ https://www.ncbi.nlm.nih.gov/pubmed/16451613 http://dx.doi.org/10.1186/1471-2156-6-S1-S152 |
work_keys_str_mv | AT suarezbriank ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT taylorchelsea ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT bertelsensarah ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT bierutlauraj ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT dunngerald ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT jincarolh ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT kauwejohnsk ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT patersonandrewd ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT hinrichsanthonyl ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT suarezbriank analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT taylorchelsea analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT bertelsensarah analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT bierutlauraj analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT dunngerald analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT jincarolh analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT kauwejohnsk analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT patersonandrewd analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms AT hinrichsanthonyl analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms |